Century Therapeutics, Inc. - Common Stock - relatórios financeiros (NASDAQ:IPSC) | MetaTrader

Abrir gráfico completo Full chart

Notícias

Mizuho inicia cobertura da Century Therapeutics com recomendação de Outperform

H.C. Wainwright eleva preço-alvo da Century Therapeutics com base no potencial da terapia para diabetes

Century Therapeutics atualiza programa de oferta de ações com US$ 131,6 milhões restantes

Leerink reiterates Market Perform on Century Therapeutics stock

TD Cowen inicia cobertura de Century Therapeutics com recomendação de compra

TD Cowen initiates Century Therapeutics stock rating at Buy

Clear Street reitera recomendação de compra para ações da Century Therapeutics a US$ 6,60

Oracle, Palantir among market cap stock movers on Monday

Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know

Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler

Preço-alvo das ações da Century Therapeutics reduzido para US$ 6,60 pela Clear Street

Century Therapeutics stock price target lowered to $6.60 at Clear Street